JP2022533340A5 - - Google Patents

Info

Publication number
JP2022533340A5
JP2022533340A5 JP2021567913A JP2021567913A JP2022533340A5 JP 2022533340 A5 JP2022533340 A5 JP 2022533340A5 JP 2021567913 A JP2021567913 A JP 2021567913A JP 2021567913 A JP2021567913 A JP 2021567913A JP 2022533340 A5 JP2022533340 A5 JP 2022533340A5
Authority
JP
Japan
Prior art keywords
fluorocyclopropyl
imidazo
oxadiazole
carboxamide
methylphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021567913A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022533340A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2020/090060 external-priority patent/WO2020228746A1/en
Publication of JP2022533340A publication Critical patent/JP2022533340A/ja
Publication of JP2022533340A5 publication Critical patent/JP2022533340A5/ja
Pending legal-status Critical Current

Links

JP2021567913A 2019-05-13 2020-05-13 Ｎ－（５－（５－（（１Ｒ，２Ｓ）－２－フルオロシクロプロピル）－１，２，４－オキサジアゾール－３－イル）－２－メチルフェニル）イミダゾ［１，２－ａ］ピリジン－３－カルボキサミドの結晶形態 Pending JP2022533340A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2019086582 2019-05-13
CNPCT/CN2019/086582 2019-05-13
PCT/CN2020/090060 WO2020228746A1 (en) 2019-05-13 2020-05-13 Crystalline forms of n- (5- (5- ( (1r, 2s) -2-fluorocyclopropyl) -1, 2, 4-oxadiazol-3-yl) -2-methylphenyl) imidazo [1, 2-a] pyridine-3-carboxamide

Publications (2)

Publication Number Publication Date
JP2022533340A JP2022533340A (ja) 2022-07-22
JP2022533340A5 true JP2022533340A5 (https=) 2023-06-02

Family

ID=73289607

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021567913A Pending JP2022533340A (ja) 2019-05-13 2020-05-13 Ｎ－（５－（５－（（１Ｒ，２Ｓ）－２－フルオロシクロプロピル）－１，２，４－オキサジアゾール－３－イル）－２－メチルフェニル）イミダゾ［１，２－ａ］ピリジン－３－カルボキサミドの結晶形態

Country Status (14)

Country Link
US (1) US20220194936A1 (https=)
EP (1) EP3969453A4 (https=)
JP (1) JP2022533340A (https=)
KR (1) KR20220007650A (https=)
CN (1) CN114096538A (https=)
AU (1) AU2020274564A1 (https=)
BR (1) BR112021022685A2 (https=)
CA (1) CA3139552A1 (https=)
IL (1) IL287877A (https=)
MA (1) MA55976A (https=)
MX (1) MX2021013814A (https=)
SG (1) SG11202112281UA (https=)
TW (1) TW202108581A (https=)
WO (1) WO2020228746A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022016021A1 (en) * 2020-07-15 2022-01-20 Third Harmonic Bio, Inc. Crystalline forms of a selective c-kit kinase inhibitor
US20220175740A1 (en) * 2020-11-19 2022-06-09 Novartis Ag Pharmaceutical compositions of a selective c-kit kinase inhibitor and methods for making and using same
EP4247368A4 (en) * 2020-11-19 2024-10-23 Third Harmonic Bio, Inc. PHARMACEUTICAL COMPOSITIONS OF A SELECTIVE C-KIT KINASE INHIBITOR AND METHODS FOR THE PREPARATION AND USE THEREOF
IL321144A (en) 2022-11-30 2025-07-01 Blueprint Medicines Corp History of N-phenyl-pyrazolo[5,1-A]pyridine-3-carboxamide as wild-type C-KIT kinase inhibitors for the treatment of erectile dysfunction
TW202542157A (zh) * 2024-01-04 2025-11-01 大陸商上海翰森生物醫藥科技有限公司 多環類衍生物抑制劑、其製備方法和應用
WO2025256609A1 (en) * 2024-06-13 2025-12-18 Third Harmonic Bio, Inc. Crystalline forms of a selective c-kit kinase inhibitor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014525450A (ja) * 2011-09-01 2014-09-29 アイアールエム・リミテッド・ライアビリティ・カンパニー ｃ−Ｋｉｔキナーゼ阻害剤としての化合物および組成物
US9199981B2 (en) * 2011-09-01 2015-12-01 Novartis Ag Compounds and compositions as C-kit kinase inhibitors
EA201490537A1 (ru) * 2011-09-01 2014-07-30 АйАрЭм ЭлЭлСи СОЕДИНЕНИЯ И КОМПОЗИЦИИ В КАЧЕСТВЕ ИНГИБИТОРОВ КИНАЗЫ C-Kit
EP2751104B1 (en) * 2011-09-01 2019-09-25 Novartis AG Compounds and compositions as c-kit kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2022533340A5 (https=)
CA2752319C (en) Tosylate salt of a 5-pyrazolyl-2-pyridone derivative, useful in the treatment of copd
JP5894153B2 (ja) ニロチニブ塩及びそれらの結晶性形態
JP2026048795A (ja) Ｌｎｐ０２３の結晶形態
JP2026031970A (ja) Ｇｌｐ－１受容体アゴニストの結晶形ａおよびその調製法
JP5635181B2 (ja) ニトロイミダゾール系化合物、その製造方法および用途
WO2024206339A1 (en) Quinolinone amide compounds and uses thereof
US20110183999A1 (en) Novel polymorphic forms of methyl carbamate
TWI834634B (zh) 醫藥化合物、其鹽類、其製劑及其等之製備和使用之方法
JP2018522945A5 (https=)
TWI765086B (zh) Parp-1抑制劑的晶型及其製備方法
US20120316183A1 (en) Novel solvates of methylcarbamate
JP6818031B2 (ja) モルホリン誘導体の塩、結晶形、その製造方法、これらを含む医薬組成物およびその用途
JP2021529175A5 (https=)
DK2768821T3 (en) SOLID FORMS OF (1,1-DIOXO-4-THIOMORPHOLINYL) - [6 - [[3- (4-FLUORPHENYL) -5-METHYL-4-ISOXAZOLYL] METHOXY] -3-PYRIDINYL] -METHANONE
WO2020156162A1 (zh) Mek抑制剂及其在医药上的应用
KR102802551B1 (ko) 1-설포닐 피롤 유도체의 신규 염, 이의 제조 방법 및 이를 포함하는 약학 조성물
JP2022530889A (ja) ジアミノピリミジン化合物又はその水和物の固体形態、その調製方法及びその適用
JP2021522348A5 (https=)
KR20150054860A (ko) 포스파티딜이노시톨 3-키나아제 억제제의 정제 제형
WO2017175854A1 (ja) １，５－ベンゾジアゼピン化合物の結晶
TW202600558A (zh) 醛固酮合成酶抑制劑之固體形式
KR20260002254A (ko) 이미다조[1,2-a]피리딘 화합물의 신규 염의 결정형 및 이의 제조방법
KR20190022416A (ko) 신규한 트립토판 수산화효소 저해제 및 이를 포함하는 약학적 조성물
KR20260002253A (ko) 이미다조[1,2-a]피리딘 화합물의 신규 염 및 이의 제조방법